Summary
- Current Price
- As of today, CTXR price is $0.85, up +1.30% on
- Current Price All-Time High
- CTXR price is currently -99.91% below its historical high of $937.50 set on an earlier date
- Market Cap
- CTXR current market cap is $19M, up +73.01% over the past 365 days
- PE Ratio
- CTXR PE ratio is unknown
- Revenue
- CTXR current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for CTXR is on
Profile
| Metric | Value |
|---|---|
| Full Name | Citius Pharmaceuticals, Inc. |
| Ticker | NASDAQ: CTXR |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | citiuspharma.com |
| Employees | 23 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.85 | ||
| Price, 1D Change | +1.30% | |
| $19M | ||
| - | ||
| - | ||
| 1.72 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.38 | ||
| EPS, 1Y Change | +43.37% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.38 | ||
| EPS Estimate | N/A | $1.66 |
| EPS Est. Change | N/A | +149.07% |
| $0.00 | ||
| Revenue Estimate | N/A | $78.29M |
| Revenue Est. Change | N/A | - |
| $0.85 | ||
| Price Target | - | $6.00 |
| Price Tgt. Change | - | +602.58% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.63 | -$5.97 | -6.20% | |
| -$2.08 | -$3.38 | -62.64% | |
| $1.66 | N/A | +149.07% | |
| $2.79 | N/A | +182.47% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $78.29M | N/A | - | |
| $158.00M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -27.63% | ||
| -97.08% | ||
| +73.01% | ||
| -88.84% | ||
| 0.00% | ||
| 0.00% | ||
| +43.37% | ||
| +41.24% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.85 | ||
| $1.16 | ||
| SMA 200 vs Price | +35.25% | |
| $0.79 | ||
| SMA 50 vs Price | -7.35% | |
| 1.72 | ||
| $0.09 | ||
| 54.22 | ||
| 183.09% | ||
| 130.13% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$3.38 | ||
| -$214.20K | ||
| - | ||
| -$38.53M | ||
| - | ||
| -$39.74M | ||
| - | ||
| -$38.31M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.03 | ||
| 0.62 | ||
| 0.13 | ||
| - | ||
| - | ||
| -3.46 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 4.85 | ||
| 0.24 | ||
| -0.36 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $67.55M | ||
| $4.25M | ||
| $131.16M | ||
| $27.93M | ||
| $53.63M | ||
| $44.91M | ||
| $1.81M | ||
| $1.09M | ||
| $13.69M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $37.43M | ||
| $38.31M | ||
| $214.20K | ||
| $0.00 | ||
| $214.20K | ||
| $0.00 | ||
| $1.06M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$26.55M | ||
| -$5.75M | ||
| $33.30M | ||
| $5.75M | ||
| -$32.30M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| Maxim Group | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with CTXR
FAQ
What is the ticker symbol for Citius Pharmaceuticals, Inc.?
The ticker symbol for Citius Pharmaceuticals, Inc. is NASDAQ:CTXR
Does Citius Pharmaceuticals, Inc. pay dividends?
No, Citius Pharmaceuticals, Inc. does not pay dividends
What sector is Citius Pharmaceuticals, Inc. in?
Citius Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Citius Pharmaceuticals, Inc. in?
Citius Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Citius Pharmaceuticals, Inc. based in?
Citius Pharmaceuticals, Inc. is headquartered in United States
When did Citius Pharmaceuticals, Inc. go public?
Citius Pharmaceuticals, Inc. initial public offering (IPO) was on October 2, 2014
Is Citius Pharmaceuticals, Inc. in the S&P 500?
No, Citius Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Citius Pharmaceuticals, Inc. in the NASDAQ 100?
No, Citius Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Citius Pharmaceuticals, Inc. in the Dow Jones?
No, Citius Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Citius Pharmaceuticals, Inc. last earnings report?
Citius Pharmaceuticals, Inc.'s most recent earnings report was on February 13, 2026
When does Citius Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Citius Pharmaceuticals, Inc. is May 13, 2026
Data Sources & References
- CTXR Official Website citiuspharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1506251/000121390026015878/0001213900-26-015878-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1506251/000121390025125333/0001213900-25-125333-index.htm
- CTXR Profile on Yahoo Finance finance.yahoo.com/quote/CTXR
- CTXR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ctxr